Latest Regulatory Risks News

Page 3 of 30
SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.
Ada Torres
Ada Torres
28 Aug 2026
NobleOak Life delivered robust FY26 results with in-force premiums climbing 18% to $549.2 million and underlying NPAT up 15%, driven by strong market share gains and operational efficiency.
Claire Turing
Claire Turing
28 Aug 2026
McMillan Shakespeare (ASX:MMS) reported a 13.8% rise in underlying net profit after tax and amortisation to $107.9 million for FY26, driven by strong novated lease growth and accelerating electric vehicle adoption.
Claire Turing
Claire Turing
28 Aug 2026
Dubber Corporation Limited (ASX:DUB) posted a 17% revenue drop in FY26 to $35.1 million, mainly due to a major contract loss in Europe, but narrowed its net loss by 78% excluding impairments and achieved cash flow breakeven in H2.
Sophie Babbage
Sophie Babbage
27 Aug 2026
Domino’s Pizza Enterprises reported a $134.2 million statutory loss for FY26 due to significant non-cash impairments, while underlying profit rose 4%. The company is closing up to 60 stores and focusing on franchisee profitability and cost reductions.
Victor Sage
Victor Sage
26 Aug 2026
Evolution Energy Minerals has regained full rights to its Chilalo Graphite Project licence in Tanzania, clearing a significant regulatory hurdle and reaffirming its target to begin production by October 2027.
Maxwell Dee
Maxwell Dee
26 Aug 2026
HiTech Group has secured unconditional ACCC clearance for its acquisition of Hudson Global Resources’ Australian assets, removing a major regulatory obstacle ahead of completion.
Victor Sage
Victor Sage
26 Aug 2026
AdAlta Limited (ASX:1AD) has progressed its ‘East to West’ cellular immunotherapy strategy by securing its first CAR-T asset, advancing Australian manufacturing and US FDA regulatory engagement, while raising A$5.3 million in FY2026 and reporting a net loss of $4.68 million.
Ada Torres
Ada Torres
21 Aug 2026
Prescient Therapeutics cut its net loss by 4.4% to $7 million in FY26 while expanding its PTX-100 Phase 2a trial across three continents and securing key regulatory designations in Europe and the US.
Ada Torres
Ada Torres
21 Aug 2026
Santos Limited's half-year results show a 19% drop in net profit to US$355 million amid higher production and LNG ramp-up costs, while declaring an interim dividend of 11.6 US cents per share.
Maxwell Dee
Maxwell Dee
19 Aug 2026
BHP Group Limited posted robust FY2026 results with a 15% revenue increase, record copper production contributing over half of underlying EBITDA, and a total fully franked dividend of 172 US cents per share. The company advances growth projects, including the Jansen potash mine, while managing legacy Samarco liabilities and pursuing climate targets.
Maxwell Dee
Maxwell Dee
18 Aug 2026
Great Western Exploration (ASX: GTE) has entered a farm-in deal to earn up to 100% of the McKinlay Copper-Gold and Silver Project near Cloncurry, Queensland, targeting Ernest Henry-style IOCG and Cannington-style silver-lead deposits with a planned drilling campaign.
Maxwell Dee
Maxwell Dee
18 Aug 2026

Browse the archive

Full archive